LONGITUDINAL OVARIAN RESERVE CHANGES IN WOMEN WITH BREAST CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR TAMOXIFEN-ALONE
Shari B Goldfarb, Volkan Turan, Giuliano Bedoschi, Enes Taylan, Nadia Abdo, Tessa Cigler, Heejung Bang, Sujita Patil, Maura N Dickler, View ORCID ProfileKutluk H Oktay
doi: https://doi.org/10.1101/2020.06.21.20136689
Shari B Goldfarb
1Memorial Sloan Kettering Cancer Center, New York, NY, USA
2Weill Cornell Medical Center, New York, NY, USA
MDVolkan Turan
3Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
4Department of Obstetrics and Gynecology, Health and Technology University School of Medicine, Istanbul, Turkey
MDGiuliano Bedoschi
3Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
5Department of Obstetrics and Gynecology, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil
MDEnes Taylan
3Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
MDNadia Abdo
1Memorial Sloan Kettering Cancer Center, New York, NY, USA
BSTessa Cigler
2Weill Cornell Medical Center, New York, NY, USA
MDHeejung Bang
6Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, CA, USA
PhDSujita Patil
1Memorial Sloan Kettering Cancer Center, New York, NY, USA
PhDMaura N Dickler
1Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDKutluk H Oktay
3Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
MD, PhDArticle usage
Posted June 25, 2020.
LONGITUDINAL OVARIAN RESERVE CHANGES IN WOMEN WITH BREAST CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR TAMOXIFEN-ALONE
Shari B Goldfarb, Volkan Turan, Giuliano Bedoschi, Enes Taylan, Nadia Abdo, Tessa Cigler, Heejung Bang, Sujita Patil, Maura N Dickler, Kutluk H Oktay
medRxiv 2020.06.21.20136689; doi: https://doi.org/10.1101/2020.06.21.20136689
LONGITUDINAL OVARIAN RESERVE CHANGES IN WOMEN WITH BREAST CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR TAMOXIFEN-ALONE
Shari B Goldfarb, Volkan Turan, Giuliano Bedoschi, Enes Taylan, Nadia Abdo, Tessa Cigler, Heejung Bang, Sujita Patil, Maura N Dickler, Kutluk H Oktay
medRxiv 2020.06.21.20136689; doi: https://doi.org/10.1101/2020.06.21.20136689
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)